Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder

Ann C. Childress; Judith C. Kando; Thomas R. King; Antonio Pardo; Barry K. Herman

doi:10.1089/cap.2018.0078

Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2018.0078 ◽

2019 ◽

Vol 29 (1) ◽

pp. 2-8 ◽

Cited By ~ 1

Author(s):

Ann C. Childress ◽

Judith C. Kando ◽

Thomas R. King ◽

Antonio Pardo ◽

Barry K. Herman

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Pilot Study ◽

Attention Deficit ◽

Early Onset ◽

Extended Release ◽

Oral Suspension ◽

Efficacy And Safety ◽

Hyperactivity Disorder

Download Full-text

6.9 Early-Onset Efficacy and Safety Pilot Study of Amphetamine Extended-Release Oral Suspension in the Treatment of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2017.09.354 ◽

2017 ◽

Vol 56 (10) ◽

pp. S278-S279

Author(s):

Ann Childress ◽

Sally Berry ◽

Antonio Pardo ◽

Heidi W. Belden

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Pilot Study ◽

Attention Deficit ◽

Early Onset ◽

Extended Release ◽

Oral Suspension ◽

Efficacy And Safety ◽

Hyperactivity Disorder

Download Full-text

Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2017.0095 ◽

2018 ◽

Vol 28 (5) ◽

pp. 306-313 ◽

Cited By ~ 9

Author(s):

Ann C. Childress ◽

Sharon B. Wigal ◽

Matthew N. Brams ◽

John M. Turnbow ◽

Yulia Pincus ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Efficacy And Safety ◽

Hyperactivity Disorder

Download Full-text

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Extended Release Formulation ◽

Hyperactivity Disorder ◽

Delayed Release

Download Full-text

Amphetamine extended-release oral suspension for attention-deficit/hyperactivity disorder

Expert Review of Clinical Pharmacology ◽

10.1080/17512433.2019.1659723 ◽

2019 ◽

Vol 12 (10) ◽

pp. 965-971

Author(s):

Ann C. Childress ◽

Heather Chow

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder

Download Full-text

Correction to: Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use

Drugs & Therapy Perspectives ◽

10.1007/s40267-018-0567-2 ◽

2018 ◽

Vol 34 (12) ◽

pp. 596-596

Author(s):

Katherine A. Lyseng-Williamson

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder ◽

Orally Disintegrating Tablets

Download Full-text

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.05.021 ◽

2020 ◽

Vol 42 (8) ◽

pp. 1452-1466 ◽

Cited By ~ 2

Author(s):

Azmi Nasser ◽

Tesfaye Liranso ◽

Toyin Adewole ◽

Nicholas Fry ◽

Joseph T. Hull ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Controlled Trial ◽

Phase Iii ◽

School Age Children ◽

School Age ◽

Efficacy And Safety ◽

Once Daily ◽

Hyperactivity Disorder

Download Full-text

Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison

European Child & Adolescent Psychiatry ◽

10.1007/s00787-017-0962-6 ◽

2017 ◽

Vol 26 (8) ◽

pp. 875-897 ◽

Cited By ~ 13

Author(s):

Alain Joseph ◽

Rajeev Ayyagari ◽

Meng Xie ◽

Sean Cai ◽

Jipan Xie ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Mixed Treatment Comparison ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Hyperactivity Disorder ◽

Treatment Comparison ◽

Mixed Treatment

Download Full-text

Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2017.0065 ◽

2018 ◽

Vol 28 (1) ◽

pp. 29-35 ◽

Cited By ~ 2

Author(s):

Carolyn R. Sikes ◽

Russ L. McMahen ◽

Jeffrey G. Stark ◽

Dorothy Engelking

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Oral Suspension ◽

Hyperactivity Disorder

Download Full-text

Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: A 4-week, randomized, double-blind, placebo-controlled, parallel-group study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.02.011 ◽

2006 ◽

Vol 28 (2) ◽

pp. 266-279 ◽

Cited By ~ 64

Author(s):

Thomas J. Spencer ◽

Timothy E. Wilens ◽

Joseph Biederman ◽

Richard H. Weisler ◽

Stephanie C. Read ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Parallel Group Study ◽

Parallel Group ◽

Adolescent Patients

Download Full-text

Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/01.chi.0000220847.41027.5d ◽

2006 ◽

Vol 45 (7) ◽

pp. 817-823 ◽

Cited By ~ 41

Author(s):

LAURENCE L. GREENHILL ◽

RAFAEL MUNIZ ◽

ROBERTA R. BALL ◽

ALAN LEVINE ◽

LINDA PESTREICH ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Hyperactivity Disorder

Download Full-text